Time-Dependent Potentiation of the PERK Branch of UPR by GPR68 Offers Protection in Brain Ischemia
Open Access
- 1 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (10) , 2510-2521
Abstract
BACKGROUND: In ischemia, acidosis occurs in/around injured tissue and parallels disease progression. Therefore, targeting an acid-sensitive receptor offers unique advantages in achieving the spatial and temporal specificity required for therapeutic interventions. We previously demonstrated that increased expression of GPR68 (G protein-coupled receptor 68), a proton-sensitive G protein-coupled receptor, mitigates ischemic brain injury. Here, we investigated the mechanism underlying GPR68-dependent protection. METHODS: We performed biochemical and molecular analyses to examine poststroke signaling. We used in vitro brain slice cultures and in vivo mouse transient middle cerebral artery occlusion (tMCAO) models to investigate ischemia-induced injuries. RESULTS: GPR68 deletion reduced PERK (protein kinase R-like ER kinase) expression in mouse brain. Compared with the wild-type mice, the GPR68-/- (knockout) mice exhibited a faster decline in eIF2α (eukaryotic initiation factor-2α) phosphorylation after tMCAO. Ogerin, a positive modulator of GPR68, stimulated eIF2α phosphorylation at 3 to 6 hours after tMCAO, primarily in the ipsilateral brain tissue. Consistent with the changes in eIF2α phosphorylation, Ogerin enhanced tMCAO-induced reduction in protein synthesis in ipsilateral brain tissue. In organotypic cortical slices, Ogerin reduced pH 6 and oxygen-glucose deprivation–induced neurotoxicity. Following tMCAO, intravenous delivery of Ogerin reduced brain infarction in wild-type but not knockout mice. Coapplication of a PERK inhibitor abolished Ogerin-induced protection. Delayed Ogerin delivery at 5 hours after tMCAO remained protective, and Ogerin has a similar protective effect in females. Correlated with these findings, tMCAO induced GPR68 expression at 6 hours, and Ogerin alters post-tMCAO proinflammatory/anti-inflammatory cytokine/chemokine expression profile. CONCLUSIONS: These data demonstrate that GPR68 potentiation leads to neuroprotection, at least in part, through enhancing PERK-eIF2α activation in ischemic tissue but has little impact on healthy tissue.Keywords
This publication has 46 references indexed in Scilit:
- Mechanisms Underlying Suppression of Protein Synthesis Induced by Transient Focal Cerebral Ischemia in Mouse BrainExperimental Neurology, 2002
- Molecular Pathways of Protein Synthesis Inhibition during Brain Reperfusion: Implications for Neuronal Survival or DeathJournal of Cerebral Blood Flow & Metabolism, 2002
- Changes in the phosphorylation of initiation factor eIF‐2α, elongation factor eEF‐2 and p70 S6 kinase after transient focal cerebral ischaemia in miceJournal of Neurochemistry, 2001
- Protein Aggregation after Focal Brain Ischemia and ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2001
- Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERKJournal of Neurochemistry, 2001
- Evolution of Brain Infarction after Transient Focal Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Penumbral tissue alkalosis in focal cerebral ischemia: Relationship to energy metabolism, blood flow, and steady potentialAnnals of Neurology, 2000
- A Semiautomated Method for Measuring Brain Infarct VolumeJournal of Cerebral Blood Flow & Metabolism, 1990
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986
- Lactic Acidosis in the Brain: Occurrence, Triggering Mechanisms and Pathophysiological Importance1982